Xu Han serves as a Chief Technology Officer at Huston Labs LLC. In 2017, he cofounded MD3 LLC (a mobile diagnosis detection device company) and C-Dots LLC (a pharmaceutical company). He obtained PhD degree from the University of Miami, FL, USA in 2017. From 2008 to 2012, he achieved Bachelor of Science in chemistry from Nankai University, China, and Bachelor of Engineering in chemical engineering from Tianjin University, China, respectively.
Xu Han's Research mainly focuses on Drug Delivery System, Biosensing Nanotechnology, Protein or Peptide Fibrillation, and Nanolithography.